Cerebrolysin as an early add-on to reperfusion therapy: risk of hemorrhagic transformation after ischemic stroke (cerehetis). a prospective, randomized, multicenter pilot study

HIGHLIGHTS

  • who: Dina R. Khasanova from the National Institutes of Health Stroke Scale (NIHSS) on day , and, and the modified Rankin scale (mRS) on day , have published the article: Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS). A prospective, randomized, multicenter pilot study, in the Journal: (JOURNAL)
  • what: The rate of symptomatic HT observed in the study was higher than it was reported in other IVT clinical trials .
  • how: The power calculation of the study was based on efficacy assumptions which proved to be not . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?